Advertisement
Home »

Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophrenia.

Jan 16, 2023

ABOUT THE EXPERTS

  • Kamiyu Ogyu

    Department of Neuropsychiatry, Keio University School of Medicine, Tokyo 160-8582, Japan; Department of Psychiatry, National Hospital Organization Shimofusa Psychiatric Medical Center, Chiba 266-0007, Japan.

    Karin Matsushita

    Department of Neuropsychiatry, Keio University School of Medicine, Tokyo 160-8582, Japan.

    Shiori Honda

    Department of Neuropsychiatry, Keio University School of Medicine, Tokyo 160-8582, Japan.

    Masataka Wada

    Department of Neuropsychiatry, Keio University School of Medicine, Tokyo 160-8582, Japan.

    Shunsuke Tamura

    Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.

    Kazumasa Takenouchi

    Department of Clinical Laboratory Medicine, National Hospital Organization Shimofusa Psychiatric Medical Center, Chiba 266-0007, Japan.

    Yui Tobari

    Department of Neuropsychiatry, Keio University School of Medicine, Tokyo 160-8582, Japan; Faculty of Environment and Information Studies, Keio University, Kanagawa, Kanagawa 252-0882, Japan.

    Keisuke Kusudo

    Department of Psychiatry, National Hospital Organization Chiba Medical Center, Chiba 260-8606, Japan.

    Hideo Kato

    Department of Epileptology, National Center of Neurology and Psychiatry Hospital, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8551, Japan.

    Teruki Koizumi

    Department of Psychiatry, National Hospital Organization Shimofusa Psychiatric Medical Center, Chiba 266-0007, Japan.

    Naohiro Arai

    Department of Neuropsychiatry, Keio University School of Medicine, Tokyo 160-8582, Japan.

    Akihiro Koreki

    Department of Psychiatry, National Hospital Organization Shimofusa Psychiatric Medical Center, Chiba 266-0007, Japan.

    Mie Matsui

    Department of Clinical Cognitive Neuroscience, Institute of Liberal Arts and Science, Kanazawa University, Kanazawa 920-1164, Japan.

    Hiroyuki Uchida

    Department of Neuropsychiatry, Keio University School of Medicine, Tokyo 160-8582, Japan.

    Shinya Fujii

    Faculty of Environment and Information Studies, Keio University, Kanagawa, Kanagawa 252-0882, Japan.

    Mitsumoto Onaya

    Department of Psychiatry, National Hospital Organization Shimofusa Psychiatric Medical Center, Chiba 266-0007, Japan.

    Yoji Hirano

    Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan; Department of Psychiatry, Faculty of Medicine, University of Miyazaki, Miyazaki 889-1692, Japan.

    Masaru Mimura

    Department of Neuropsychiatry, Keio University School of Medicine, Tokyo 160-8582, Japan.

    Shinichiro Nakajima

    Department of Neuropsychiatry, Keio University School of Medicine, Tokyo 160-8582, Japan; Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON M6J 1H4, Canada. Electronic address: shinichiro.l.nakajima@gmail.com.

    Yoshihiro Noda

    Department of Neuropsychiatry, Keio University School of Medicine, Tokyo 160-8582, Japan. Electronic address: yoshi-tms@keio.jp.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement